doxazosin

Generic: doxazosin mesylate

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin mesylate
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 2 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-482
Product ID 71610-482_5d499a9f-8647-4ede-bb94-ad6f2302d14f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209013
Listing Expiration 2026-12-31
Marketing Start 2018-04-17

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610482
Hyphenated Format 71610-482

Supplemental Identifiers

RxCUI
197626
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin mesylate (source: ndc)
Application Number ANDA209013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (71610-482-60)
source: ndc

Packages (1)

71610-482-60 90 TABLET in 1 BOTTLE (71610-482-60)

Ingredients (1)

doxazosin mesylate (2 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5d499a9f-8647-4ede-bb94-ad6f2302d14f", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197626"], "spl_set_id": ["6b74b18f-b89a-4109-a29e-c4fa65a3c5ee"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-482-60)", "package_ndc": "71610-482-60", "marketing_start_date": "20201110"}], "brand_name": "Doxazosin", "product_id": "71610-482_5d499a9f-8647-4ede-bb94-ad6f2302d14f", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-482", "generic_name": "Doxazosin Mesylate", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "2 mg/1"}], "application_number": "ANDA209013", "marketing_category": "ANDA", "marketing_start_date": "20180417", "listing_expiration_date": "20261231"}